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BACKGROUND: The Sloane Project, an audit of UK screen-detected non-invasive carcinomas and atypical hyperplasias of the breast, has
accrued over 5000 cases in 5 years; with paired radiological and pathological data for 2564 ductal carcinoma in situ (DCIS) cases at
the point of this analysis. We have compared the radiological estimate of DCIS size with the pathological estimate of DCIS size. We
have correlated these sizes with histological grade, specimen-handling methods, particularly the use of specimen slice radiographs, and
the success or failure of breast-conserving surgery (BCS).
METHODS: The Sloane Project database was interrogated to extract information on all patients diagnosed with DCIS with complete
radiological and pathological data on the size of DCIS, nuclear grade, specimen handling (with particular reference to specimen
radiographs) and whether primary BCS was successful or whether the patient required further conservation surgery or a mastectomy.
RESULTS: Of 2564 patients in the study, 2013 (79%) had attempted BCS and 1430 (71%) had a successful single operation. Of the 583
BCS patients who required further surgery, 65% had successful conservation and 97% of them after a single further operation. In
successful one-operation BCS patients, there was a close agreement between radiological and pathological DCIS size with radiology
tending to marginally overestimate the disease extent. In multiple-operation BCS, radiology underestimated DCIS size in 59% of
cases. The agreement between pathological and radiological size of DCIS was poor in mastectomies but was improved by specimen
slice radiography, suggesting specimen-handling techniques as a cause.
CONCLUSION: In 30% of patients undergoing BCS for DCIS, preoperative imaging underestimates the extent of disease resulting in a
requirement for further surgery. This has implications for the further improvement of preoperative imaging and non-operative
diagnosis of DCIS so that second operations are reduced to a minimum.
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The clinical management of ductal carcinoma in situ (DCIS) of the
breast remains problematic. The disease is thought to spread
radially along the duct systems in the breast (Faverly et al, 1994;
Vicini et al, 2001), and treatment demands a close cooperation
between surgeons, radiologists and pathologists if the true
size of the disease can be accurately assessed preoperatively.
The radiologist will identify the mammographic abnormality, but
crucially must help the surgeon by accurate measurement. The
surgeon must meticulously orientate the surgical specimen to help
the pathologist define the margins. It has been previously shown
that there is a correlation between size of disease and the
requirement for further surgery, underlining the need for accurate
preoperative assessment (Vicini et al, 2001).
The Sloane Project (The Sloane Project, 2009), named in
memory of the late Professor John Sloane, is a prospective UK
audit of patients with screen-detected non-invasive carcinomas
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sand atypical hyperplasias of the breast detected by the National
Health Service Breast Screening Programme (NHSBSP). The audit
started in 2003 with the aim of assessing the effect of current
clinical management on the long-term outcome of patients. All the
UK NHSBSP breast-screening units are encouraged to participate
in the project, and 77 out of 95 (81%) of the UK screening units
voluntarily submit the data. Each clinical specialty in a screening
unit contributes profession-specific data relating to diagnosis and
treatment using specially designed data collection forms. The data
recorded include details of specimen radiology and orientation, the
radiological and pathological size, and surgical margins. There is
published guidance for the UK Breast Screening Programme on the
optimal standards for specimen handling of the resected DCIS
(Ellis et al, 2005). Further guidance is also available from the
Sloane Project website (The Sloane Project, 2009).
The key problem in treating patients with DCIS is tumour-
positive surgical margins after breast-conserving surgery (BCS),
which is likely to be associated with residual DCIS and a high risk
of local recurrence (Dunne et al, 2009). Prevention of local
recurrence is the main issue in treating patients with a curable in
situ carcinoma as half of these recurrences are invasive carcinomas
(Silverstein et al, 1998). This underlines the value of accurate
preoperative measurement to guide BCS.
This paper examines specifically the relationship between
radiological and pathological size measurements, their relationship
to DCIS grade, specimen-handling techniques (particularly speci-
men slice radiography) and whether BCS was successful as a
primary procedure.
MATERIALS AND METHODS
The period of study covered all entrants to the Sloane Project from
its inception in April 2003–December 2008 – over 5000 patients.
All patients were screen-detected with an age range of 50–70 years
and a screening interval of 3 years. Approximately 70% of the
entered patients had either a missing pathological or radiological
data form at the time of analysis with some overlap giving an
initial study population of 3883 patients who had both pathological
and radiological data forms. In total, a further1319 cases were
excluded from the study for the following reasons: unpaired
pathological/radiological measurements (644), atypical ductal
hyperplasia and/or lobular in situ neoplasia alone or in combina-
tion with DCIS (304), inappropriate first operation recorded (e.g.,
axillary surgery only, therapeutic re-excision) (39), DCIS grade not
recorded (28) or if a diagnostic biopsy was performed (304) and
thus true pathological size was not assessable. There was an
overlap between these groups. The 304 diagnostic biopsies with
paired size data and in which DCIS grade was recorded were
excluded from the main study but will be analysed briefly in the
Results section.
The remaining 2564 cases on the database were interrogated to
identify three groups of patients with pure DCIS who had either
a single successful breast-conserving operation (n¼1430), a
mastectomy as a primary procedure (n¼551) or further surgery
(re-excision and/or completion mastectomy) because of failed
primary BCS the first time around (n¼583). These three groups
were compared for radiological and pathological size agreement,
DCIS grade and whether specimen slice radiography had been
carried out. These groups were chosen because they allowed a clear
comparison of factors associated with the success or failure of BCS
and also case selection for mastectomy.
We do not have precise records of imaging technique but we
estimate that 490% of patients will have received film-screen
mammography with only a small percentage receiving compu-
terised radiography or digital mammography. The Sloane Project
radiology form enables bi-dimensional recording of the disease
extent. The radiological size is the largest diameter on either the
craniocaudal or oblique view. This measurement is taken after
viewing the magnification views to look for subtle additional
calcifications, but not usually directly measured from the
magnification views. A minority of cases will have had full-field
digital mammography at assessment and in these cases the
measurements will have been done from electronic magnification
of the standard views on a digital workstation. Measurements were
not taken from specimen radiographs. Intraoperative radiographs
were read by the surgeon but had no influence on the final
determination of radiological size, which is a preoperative
measurement. For the purposes of this study, the maximum
recorded radiological size of either the length or the diameter of
the lesion was used.
The pathological measurement of DCIS size includes both the
primary excision and any additional disease found at subsequent
re-excision or mastectomy. Screen-detected DCIS in the United
Kingdom is graded by nuclear morphology alone, as guided by the
NHSBSP Reporting Guidelines (Ellis et al, 2005).
Data analysis
Data were analysed using ‘Analyse it’ version 2.20 software for
Microsoft Excel. Measurements of agreement between radiological
and pathological sizes were assessed using Altman–Bland plots to
compare the difference between two measurement techniques of a
continuous variable (pathology and radiology in this study) (Altman
and Bland, 1983; Bland and Altman, 1986). The differences between
the two paired measurements are plotted against the mean of values
obtained using the two techniques. The mean of the differences is
calculated to give a measure of ‘bias’ of one technique over the other.
This may be a positive or negative value. The differences between
radiological and pathological paired measurements for the various
subgroups were compared using the Mann–Whitney U-test.
Comparisons of frequencies were made using the w
2-test. We defined
an a-error for tests of significance at P¼0.05.
RESULTS
All cases
The distribution of DCIS grade in patients having one successful
BCS operation, primary mastectomy and failed primary BCS
groups is shown in Table 1. Overall, 67% of cases had high-grade
disease, 26% intermediate grade and 7% low grade. Those patients
who were offered mastectomy as a primary procedure had a higher
incidence of high-grade disease (80%) than those who had
successful primary BCS (60%) or unsuccessful primary BCS
(71%). These differences between groups for high-grade DCIS
are all highly significant (Pp0.0001).
Specimen radiography by the surgeon was carried out in 1811 of
2564 (71%) cases. Overall, specimen slice radiography was carried
out by pathologists in only 757 of 2564 (29%) cases. There was no
difference in the use of specimen slice radiography between women
having successful one-operation BCS or unsuccessful BCS (31 vs
32%). Of the one-operation mastectomy specimens, 22% had slice
radiography. For all cases, pathologists who elected to X-ray
specimen slices took more blocks than those who did not (one-
operation BCS: median¼12 vs 10 per case; one-operation mastec-
tomy: 17 vs 13 per case; and two operations or more: 14 vs 10 per
case). These differences are all highly significant (all Pp0.0001).
Although 445 cases out of the original 3883 had large blocks
taken as part of the specimen handling in the study population of
2564 cases, only 10 were subjected to this technique.
Patients undergoing a single BCS procedure
The agreement between median maximum radiological and patho-
logical DCIS sizes was very close in successful one-operation BCS
Radiological–pathological agreement in DCIS
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spatients (12mm vs 14mm) (Table 2). The level of agreement was
not affected by specimen slice radiography but was affected by the
DCIS grade (overall difference: 2mm in low-grade vs 1mm in
high-grade disease).
Patients undergoing a mastectomy as a primary procedure
The agreement between radiological and pathological maximum
DCIS size was less good in primary procedure mastectomy
specimens with the overall median radiological size being 18mm
larger than the pathological size (50mm vs 32mm) (Table 2). The
difference between radiological and pathological size increased
with decreasing grade (15mm for high-grade DCIS and 46mm for
low-grade disease). The level of agreement between radiological
and pathological size was generally improved by specimen slice
radiography (difference: 14mm vs 17mm for all cases) with the
exception of low-grade DCIS in which the difference increased
from 32 to 62mm, but case numbers for this group were low. An
example of an Altman–Bland plot for the primary mastectomy
group is shown in Figure 1.
Failed primary BCS – patients requiring re-excision or
mastectomy
Of the 2013 patients who underwent BCS as a primary procedure,
583 (30%) required further surgery because of involved margins.
Two-thirds of these 583 patients ultimately had successful breast
conservation, the majority of these after a single further operation.
One-third of these patients required mastectomy. These results are
summarised in Table 3.
Table 1 Grade distribution of DCIS by operation type
DCIS grade
All grades High Intermediate Low
Type of operation No. of cases No. of cases % No. of cases % No. of cases %
Successful primary BCS 1430 857 60 448 31 125 9
Primary mastectomy 551 441 80 86 16 24 4
Unsuccessful primary BCS 583 411 71 147 25 25 4
Totals 2564 1709 67 681 26 174 7
Abbreviations: BCS¼breast-conserving surgery; DCIS¼ductal carcinoma in situ.
Table 2 Radiological and pathological size measurements for each operation type and the influence of grade and specimen slice radiography
DCIS grade
All High Intermediate Low
Type of operation
Specimen
slice X-ray
Type of
size
No. of
cases
Median
size (mm)
No. of
cases
Median
size (mm)
No. of
cases
Median
size (mm)
No. of
cases
Median
size (mm)
Successful primary BCS All cases Pathological 1430 12 857 14 448 10 125 7
Radiological 1430 14 857 15 448 12 125 9
Difference 2 1 2 2
No Pathological 836 12 470 13 290 10 76 7
Radiological 836 13 470 15 290 12 76 9
Difference 1 2 2 2
Yes Pathological 455 14 305 16 108 10 42 7
Radiological 455 15 305 18 108 13 42 9
Difference 1 2 3 2
Primary mastectomy All cases Pathological 551 32 441 35 86 27 24 18
Radiological 551 49 441 50 86 46 24 64
Difference 17 15 19 46
No Pathological 168 31 127 35 34 27 7 16
Radiological 168 48 127 50 34 46 7 48
Difference 17 15 19 32
Yes Pathological 125 31 96 37 21 22 9 18
Radiological 125 45 95 48 21 37 9 80
Difference 14 11 15 62
Unsuccessful primary BCS All cases Pathological 583 22 411 24 147 19 25 27
Radiological 583 16 411 18 147 14 25 15
Difference  6  6  5  12
No Pathological 339 23 237 24 83 21 14 27
Radiological 339 16 237 19 83 14 14 12
Difference  7  5  7  15
Yes Pathological 177 20 123 24 41 17 8 22
Radiological 177 16 123 20 41 12 8 18
Difference  4  4  5  4
Abbreviations: BCS¼breast-conserving surgery; DCIS¼ductal carcinoma in situ. Note that all differences in the unsuccessful BCS group are negative.
Radiological–pathological agreement in DCIS
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sIn this group of patients, who required subsequent re-excision
in the form of additional breast conservation surgery or
mastectomy, the radiological size of DCIS was significantly greater
than the one-operation BCS group (Pp0.0001). This is true for all
histological grades (high grade: P¼0.002; intermediate grade:
P¼0.03; low grade: P¼0.02). The distribution of radiological sizes
is shown in Figure 2. The radiological size of disease was also
substantially less than that demonstrated pathologically (16mm vs
23mm) (Table 2). This mismatch was exaggerated in low-grade
DCIS (15mm vs 27mm). Specimen slice radiography improved the
agreement between radiological and pathological size (overall
difference: 4mm vs 7mm). This effect was particularly marked for
low-grade disease (7mm vs 15mm).
There was no difference in median specimen weight (55 vs 58g).
A record of whether radiological calcification was present or not was
made in 2558 out of 2564 (499%) cases. There was no significant
difference between recorded calcification in the two conservation
groups (92.0 vs 91.6%). We have not carried out a detailed review of
the type of calcification recorded in this study. A representative
Altman–Bland difference plot from this group is shown in Figure 3
demonstrating the negative measure of bias in this group.
The trend of worsening agreement between radiological and
pathological measurement of DCIS from conservation to mastect-
omy specimens, from high-grade to low-grade disease and from
successful single BCS to failed primary BCS is underlined by the
increasing Altman–Bland bias from one group to the next
(Table 4).
Although the differences between radiological and pathological
size at different grades within each group are not significant,
the difference between the one-operation BCS (n¼1430) and
the failed primary BCS (n¼583) groups as suggested by the
polarised Altman–Bland plots is highly significant (Pp0.0001).
The differences between radiological and pathological sizes
comparing the one-operation BCS group and the one-operation
mastectomy group are also highly significant (Pp0.0001) as is the
difference between radiological and pathological sizes in the one-
operation mastectomy and two-operation groups (Pp0.0001).
Radiological–pathological size differences and the
outcome of BCS
In the one-operation BCS group, 503 of 1430 patients (35%)
showed a pathological DCIS size exceeding the radiological size
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Figure 1 Altman–Bland agreement plot for primary mastectomies. The
solid line shows the measure of bias (13.33mm). The 95% confidence
intervals refer to the differences between radiological and pathological
measurements and are shown as broken lines. The colour reproduction of
the figure is available on the html full text version of the paper.
Table 3 Outcome of patients requiring further surgery for failed primary
breast-conserving surgery
No. of further operations
1 2 3 Total %
Successful Conservation 368 11 1 380 65
Mastectomy 169 30 4 203 35
Total 537 41 5 583
95% Cl Notched outlier boxplot
95% Cl Mean diamond
Outliers > 1.5 and <3 IQR
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Figure 2 Maximum radiological size distributions for successful (1
operation) vs unsuccessful (41 operation) breast conservation cases. CI,
confidence interval; IQR, interquartile range.
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Figure 3 Altman–Bland plot for agreement between radiological and
pathological size measurements for all unsuccessful (2þoperations) breast-
conserving surgery (BCS) cases. Note that the measure of overall bias is
now negative (mean:  6.46mm). The 95% confidence intervals refer to
the differences between radiological and pathological measurements and
are shown as broken lines.
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cases in which pathological size exceeded radiological size, 59%
were treated by a single operation, whereas those patients in whom
radiological size exceeded pathological size, 79% were treated
by a single operation. These differences are highly significant
(Pp0.0001). The percentage of all BCS cases treated by a single
successful conservation operation grouped by size difference is
summarised in Figure 4. When the pathological size exceeded
radiological size by 430mm, only 14% of patients received
successful single-operation BCS, whereas when radiological size
was the same or greater than pathological size, 80% of patients
received successful single operation BCS. This overall pattern was
not influenced by the DCIS grade. In those patients who underwent
eventual successful breast conservation after an initial unsuccess-
ful conservation procedure, 54% showed a radiological size that
was less than the pathological size against 71% of patients who
were finally treated by mastectomy. This difference is highly
significant (Pp0.0001).
Excluded graded diagnostic biopsies
Of the 304 diagnostic biopsies where data on histological grade of
DCIS was available, which were excluded from the study, 126
(41%) had no further surgery, suggesting that these were in fact
intended therapeutic procedures. There was a higher proportion
(25%) of low-grade DCIS in this group than in the study group
(7%) (Pp0.0001). The data relating to this group are summarised
in Table 5.
DISCUSSION
For a patient to have a successful single breast-conserving
operation for DCIS, there is a requirement for accurate pre-
operative mapping of the extent of disease. The bulk of this burden
Table 4 Altman–Bland bias as a measure of agreement between radiological and pathological measurements of DCIS by operation type and the influence
of grade and specimen slice radiography
DCIS grade
All High Intermediate Low
Type of operation Specimen slice X-ray No. of cases Bias No. of cases Bias No. of cases Bias No. of cases Bias
Successful primary BCS All cases 1430 2.96 857 2.67 448 3.46 125 3.12
No 836 3.36 470 3.10 290 3.70 76 3.80
Yes 455 2.63 305 2.40 108 3.60 42 1.80
Primary mastectomy All cases 551 13.33 441 11.35 86 18.60 24 30.70
No 168 13.00 127 11.80 34 16.00 7 19.90
Yes 125 13.10 95 10.60 21 13.80 9 37.70
Unsuccessful primary BCS All cases 583  6.46 411  6.6 147  5.06 25  12.30
No 339  7.94 237  7.48 88  8.0 14  15.60
Yes 177  3.06 123  3.7 46  1.41 8  2.10
Abbreviations: BCS¼breast-conserving surgery; DCIS¼ductal carcinoma in situ. Influence of grade and specimen slice radiography. Note that all bias values in the unsuccessful
primary BCS group in are negative.
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Table 5 Analysis of excluded graded diagnostic biopsies
DCIS grade All High Intermediate Low
Number (%) 304 114 (38) 113 (37) 77 (25)
No further surgery 126 33 46 47
Further excision to clear margins 70 29 25 16
Mastectomy
a 46 26 14 6
Wide local excision 33 16 15 2
Multiple operations
b 26 9 13 4
Axillary surgery only 1 1
Median Pathology size (mm) 12 17 10 8
Median radiology size (mm) 17 17 17 15
DCIS¼ductal carcinoma in situ.
aExcludes multiple operations group (see below).
b18 of these cases were ultimately treated by mastectomy.
Radiological–pathological agreement in DCIS
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sfalls on the radiologists, although this can be improved by using
targeted core biopsies to map the full extent of the DCIS.
Furthermore, inserting localisation wires at either end of the area
of DCIS may assist the surgeon undertaking the resection. This is
particularly useful when both benign and malignant microcalcifi-
cation are known to be present.
This study examines two methods of measuring the size of DCIS
– radiological and pathological. We have used the Altman–Bland
plot as the statistical technique to compare the differences between
radiological and pathological size assessment. For each pair of data
items, the Altman–Bland plot compares the difference between the
two measurements with the mean of those measurements. It
therefore focuses very closely on differences. The Altman–Bland
bias is the mean of these differences. A bias value of 0 indicates no
difference, whereas increasing values represent greater differences.
The 95% confidence intervals are also calculated. In contrast, a
correlation coefficient is a measure of the degree of association
between two quantities; it does not measure how closely they agree.
Its use in comparing two methods that claim to measure the same
parameter is inappropriate. In this context, we have restricted our
use of P-value calculations to the comparison of radiological–
pathological size differences in the subgroups analysed and
radiological size estimations in the two BCS groups and the
comparison of some frequencies between categorical variables.
In those patients who had successful primary BCS, there is a
close agreement between radiological and pathological DCIS size,
both in terms of median values and the Altman–Bland measures of
bias. At all grades, the bias is in favour of radiological size, with
pathological size being marginally smaller. The greatest mismatch
is for low-grade disease. This is likely to be due to less calcification
being associated with this grade of DCIS (Evans et al, 1994;
de Roos et al, 2007); however, we urge some caution against
overinterpreting the data on low-grade disease because of the rela-
tively small numbers of cases in these subgroup analyses. Screen-
detected DCIS in the United Kingdom is graded by nuclear
morphology alone, as guided by the NHSBSP Reporting Guidelines
(Ellis et al, 2005). The overall incidence of low-grade DCIS in the
present series was 7%. We excluded patients with recorded
coexistent atypical ductal hyperplasia and/or lobular in situ
neoplasia because of the potential for the extent of microcalcifica-
tion to exaggerate the extent of DCIS. The incidence of low-grade
DCIS is lower than that reported previously from an earlier cohort
of this series (11%) (Thomas et al, 2008) and is partly due to the
exclusion of cases with coexistent atypical ductal hyperplasia/
lobular in situ neoplasia in this study group. This low incidence
may also reflect the application of stringent diagnostic criteria for
grading DCIS as a result of the ongoing comprehensive training
programmes required for pathologists reporting NHSBSP screen-
detected cancers, as well as the recognised preponderance of
detection of high-grade DCIS in the NHSBSP.
In terms of successful BCS, a small radiological overestimate
of the extent of disease will guide the surgeon appropriately
with the likelihood that the DCIS in question will be excised
completely by one breast-conserving operation. We acknowledge
that overestimation of DCIS size radiologically could lead to
unnecessarily extensive surgery, but our data show that in the
successful primary BCS group the radiological overestimation of
DCIS size is generally small (1–3mm) and is therefore unlikely to
be detrimental in this context.
Comparison between those patients who have had one-opera-
tion BCS and primary mastectomy shows a similar bias in favour
of radiological size, but allows comment to be made on the
accuracy of pathologists in determining DCIS disease extent under
these circumstances. Accepting that the disease process is the same
in the two types of operative specimen, and that the match between
the radiological and pathological size in one-operation BCS
specimens is very close, it is likely that specimen handling is the
major reason for the difference in estimating DCIS extent in
patients having a mastectomy. This view is supported by the
improvement in radiological–pathological agreement when slice
radiography is used, which holds true for all tumour grades and is
particularly marked for low-grade disease. Pathologists are
encouraged to make use of slice radiography for cases in which
microcalcification is the principal feature and these data lend
support to that view (Ellis et al, 2005).
In those cases in which BCS was unsuccessful, median
pathological size is substantially greater than radiological size for
all tumour grades. This is the reverse of the situation for successful
one-operation BCS procedures. This is almost certainly due to
diminished microcalcification in association with the DCIS in this
group of patients, even though the crude statement on the Sloane
Project radiology data form ‘No calcification on mammogram’ was
answered in the negative in 10% of successful primary BCS cases
and in only 7% of failed primary BCS cases. There is no significant
difference in the median specimen weights for the two groups,
indicating that the amount of tissue removed in the two groups
were comparable. However, radiological size is, unsurprisingly,
significantly greater in those cases in which initial BCS was
unsuccessful compared with one-operation BCS cases, at all
histological grades. In the group of patients who had an
unsuccessful attempt at a single surgical BCS procedure, however,
the larger radiological size described here, and the increased
proportion of high-grade DCIS seen (71% compared with 60% in
the successful one-operation group), is not sufficiently different to
be able to guide the surgeon as to whether further imaging is
required to map the extent of disease. It is apparent from our data
that underestimation of DCIS extent radiologically need not
necessarily lead to a failed primary conservation procedure.
Surgical guidelines recommend re-excision for positive margins
and we have made the assumption that these cases were disease
free at the margins.
The meticulous studies of Holland et al comparing radiological
and pathological disease extent indicated that radiology system-
atically underestimated DCIS size and run counter to the data
presented here (Holland et al, 1990; Holland and Hendricks, 1994).
Holland’s series of cases from one surgical unit is very different
from the wide cross-section seen in the Sloane Project; in the
former series, there were much smaller numbers (83 and 119,
respectively) and the specimens were all mastectomies. In our
series, this radiological underestimation of DCIS size only applies
to the subset of failed primary BCS cases (about 30% of
conservation cases). The remaining 70% were surgically clear with
a close agreement between radiological and pathological size.
Our data from primary mastectomies show underestimation of
disease extent by pathologists who are, overall, unlikely to have
emulated Holland’s very detailed approach. A comparable study of
109 mastectomy specimens showed no significant difference
between radiological and pathological measurements of DCIS
extent (Sato et al, 2002). A more recent study of 174 cases of DCIS
showed a correlation between increasing pathological–radiological
size discrepancy and the requirement for more than one operation
(Chakrabarti et al, 2006). That study failed to show a relationship
between size discrepancy and grade, although case numbers were
considerably lower than reported here. Ultimately the significance
of these mismatches and the relevance of margin clearances will be
resolved when outcome data (recurrence and survival) emerge for
the Sloane Project cohort.
Although the Sloane Project pathology data form requests
details regarding the cut-up method used by pathologists, there is
no opportunity for the pathologist to describe his/her measure-
ment technique. It is much easier to measure the size of a lesion
in a wide local excision specimen because the sections can
either be re-assembled like a jigsaw puzzle to give an overall size or
large sections can be used that allow direct measurements. Such
use of large block histology has been shown to improve the
agreement between radiological and pathological lesion size
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following the various exclusions to be able to confirm this finding.
Alternatively, the pathologist can relate the disease to its distance
from margins and then calculate the extent from the overall
dimensions of the specimen (Lester et al, 2009). It has also been
suggested that the size may be estimated by the number of blocks
containing DCIS multiplied by a factor, but a recent study has cast
doubt on the accuracy of this approach (Dadmanesh et al, 2009).
Inconsistency among pathologists in measuring DCIS extent has
also been previously reported (Sloane et al, 1999).
We have not analysed the margin status or width in this study,
believing this to be much more pertinent to a future analysis of the
Sloane Project data examining outcomes, particularly local
recurrences, when longer follow-up is available. The overwhelming
majority of patients receiving a single successful conservation
operation have negative margins, as defined by the particular
centre. In some cases, a positive margin will not result in further
surgery – most commonly anterior or posterior margins in full-
thickness procedures. It should be appreciated that exactly what
defines a negative margin (‘complete excision’) differs from centre
to centre and that variation will itself enable an evaluation of
optimal margin clearance when outcome data become available.
Are there any developments that could lead to a reduction of
re-operation rates for DCIS? The College of American Pathologists
has recently issued guidelines on specimen handling for DCIS that
lay down stringent standards for this area of practice (Lester et al,
2009). These explicit recommendations are most likely to improve
pathological assessment of disease extent and reproducibility of
grade of DCIS and may improve detection of invasive disease. They
will however do nothing to affect accurate preoperative assessment
of disease extent, unless accompanied by the rigorous application
of radiological–pathological size correlation of both operative and
core biopsy specimens (e.g., if multiple cores are taken from areas
of microcalcification with associated pathological–radiological
mapping). More detailed discussion at the multidisciplinary
meeting of the extent of calcification within the DCIS (in one or
multiple core biopsies) can be correlated with how well the extent
of disease is likely to be represented by the mammographic
appearances, particularly in intermediate and low-grade DCIS.
The use of wide-bore, vacuum-assisted, needle biopsy may also
improve diagnosis and assessment in difficult cases (Pijnappel
et al, 2004).
Studies have suggested that magnification views can aid the
prediction of extent of low-grade DCIS (Asjoe et al, 2007;
Di Saverio et al, 2008). Our data show that the size discrepancies
leading to failed primary BCS occur across all tumour grades and
that, numerically, low-grade disease is uncommon (o10% of
cases). The overall impact of this approach to low-grade disease
alone would therefore be small. Furthermore, it has been reported
that the mammographic appearances do not correlate sufficiently
with histological grade to assist preoperative identification of this
subset of problem cases (de Roos et al, 2004). Histological
reporting of the grade of DCIS in the core biopsy specimen,
however, may prove of assistance in highlighting cases in which
size discrepancy may be greatest, as core biopsy grade of DCIS has
been shown to reflect the subsequent DCIS grade seen in surgical
excision (Bagnall et al, 2001).
Recently, attention has been focused on the value of magnetic
resonance imaging (MRI) in determining disease extent of DCIS.
A number of recent studies have compared the ability of MRI and
mammography to detect and size DCIS lesions. The results are
conflicting; a number favouring MRI (Schouten van der Velden
et al, 2006; Kim et al, 2007; van Goethem et al, 2007), another
finding the performance of MRI and mammography were similar
(Sardanelli et al, 2008) and yet another finding that the
combination of mammography and MRI was significantly better
than either of the modalities alone (Santamarı ´a et al, 2008).
The main limitation of this study relates to the inevitable range
of practice from centre to centre. Although this is minimised by
the availability of practice guidelines that have been in place in the
NHSBSP for the past 20 years, there is bound to be a degree of
variability. We have not attempted to review the data from
individual centres at this time because the numbers of cases from
each centre will be too small to analyse, but this will be possible
in the future as the Sloane Project case accrual grows and that
will allow differences in practice to be compared against the
outcomes. To minimise the effects of such variation, we have
restricted our analyses to very broad groupings of cases with large
numbers in each.
CONCLUSIONS
In a large series of screen-detected DCIS, we have shown that
current approaches to preoperative imaging undersize the extent
of disease in patients selected for BCS in up to 30% of cases, with
the consequence of failed primary conservation surgery. Never-
theless, breast conservation can still be achieved in two-thirds of
this group and by the second operation in 90% of cases.
Multidisciplinary team working is likely to have made a
substantial contribution to effective management of breast cancer
over the past 20 years and could be expected to have an impact on
DCIS. Further improvements in preoperative assessment should
include detailed discussion between surgeon, radiologist and
pathologist about radiological–pathological size correlation,
particularly the extent of colocation of microcalcification and
DCIS. Our data suggest that such discussion should be particularly
targeted at intermediate and low-grade disease.
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sParticipating Screening Units in the Sloane Project as per
October 2009
Avon
Barking, Havering, Brentwood and Redbridge
Barnsley
Basingstoke and District
Bedfordshire and Hertfordshire
Bolton, Bury and Rochdale
Breast Test Wales – North
Breast Test Wales – South East
Breast Test Wales – South West
Cambridge and Huntingdon
Central and East London
Chelmsford and Colchester
Chester
City, Sandwell and Walsall
Cornwall
Crewe
Doncaster
Dorset
Dudley and Wolverhampton
East Berkshire
East Scotland
East Sussex
Gateshead
Gloucestershire
Great Yarmouth and Waveney
Greater Manchester
Hereford and Worcester
Humberside
Isle of Wight
Jarvis
Leeds and Wakefield
Leicestershire
Liverpool
Macclesfield
Maidstone
Medway
Milton Keynes
Newcastle-Upon-Tyne
Norfolk and Norwich
North and East Devon
North Cumbria
North East Scotland
North Lancashire and South Cumbria
North London
North Nottinghamshire
North Staffordshire
North Yorkshire
Northampton
Nottingham
Oxford
Pennine (Bradford)
Peterborough
Portsmouth
Rotherham
Sheffield
Shropshire
South Birmingham
South Derbyshire
South Devon
South East London
South East Scotland
South Essex
South Staffordshire
South West London
South West Scotland
Southampton and Salisbury
Warrington
Warwickshire, Solihull and Coventry
West Berkshire
West Devon and East Cornwall
West Essex and Redbridge
West London
West Scotland
Western Breast Screening Unit, Northern Ireland
Wiltshire
Wirral
Wycombe
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